(Q48413117)

English

Quality of life in children with osteogenesis imperfecta treated with oral bisphosphonates (Olpadronate): a 2-year randomized placebo-controlled trial

scientific article published on 17 February 2007

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17308899

Quality of life in children with osteogenesis imperfecta treated with oral bisphosphonates (Olpadronate): a 2-year randomized placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17308899

osteogenesis imperfecta

0 references

1 reference

based on heuristic

inferred from title

quality of life

1 reference

based on heuristic

inferred from title

author name string

Dieke H J Kok

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17308899

Ralph J B Sakkers

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17308899

Arieke J Janse

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17308899

Hans E H Pruijs

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17308899

Ab J Verbout

5

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17308899

Rene M Castelein

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17308899

Raoul H H Engelbert

7

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17308899

publication date

17 February 2007

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17308899

European Journal of Pediatrics

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17308899

166

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17308899

11

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17308899

1155-1161

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17308899

A comparison of oral and intravenous bisphosphonate therapy for children with osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1007%2FS00431-006-0399-2

21 January 2018

Efficacy of low dose schedule pamidronate infusion in children with osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1007%2FS00431-006-0399-2

21 January 2018

Pamidronate treatment of less severe forms of osteogenesis imperfecta in children.

1 reference

https://api.crossref.org/works/10.1007%2FS00431-006-0399-2

21 January 2018

Osteogenesis imperfecta in childhood: prognosis for walking

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous Neridronate in Children With Osteogenesis Imperfecta: A Randomized Controlled Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics/pharmacodynamics of bisphosphonates: use for optimisation of intermittent therapy for osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inherited disorders of collagen gene structure and expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival, and importance of clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Temperament and physical performance in children with osteogenesis imperfecta

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of osteogenesis imperfecta with the bisphosphonate olpadronate (dimethylaminohydroxypropylidene bisphosphonate)

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteogenesis imperfecta - Clinical and molecular diversity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiattribute and single-attribute utility functions for the health utilities index mark 3 system.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonoperative treatment of osteogenesis imperfecta: orthotic and mobility management

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reliability and validity of a comprehensive health status measure in a heterogeneous population of children admitted to intensive care.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic heterogeneity in osteogenesis imperfecta

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Health Utilities Index (HUI): concepts, measurement properties and applications

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A difference in perception of quality of life in chronically ill children was found between parents and pediatricians.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Type V osteogenesis imperfecta: a new form of brittle bone disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteogenesis imperfecta: profiles of motor development as assessed by a postal questionnaire.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trials in orthopaedics: why, how, and when?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteogenesis imperfecta in childhood: impairment and disability. A prospective study with 4-year follow-up.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reliability of the Health Utilities Index--Mark III used in the 1991 cycle 6 Canadian General Social Survey Health Questionnaire.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient-focused measures of functional health status and health-related quality of life in pediatric orthopedics: a case study in measurement selection

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of elective total hip replacement on health-related quality of life.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beneficial effect of bisphosphonate during five years of treatment of severe osteogenesis imperfecta

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteogenesis imperfecta in childhood: perceived competence in relation to impairment and disability.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteogenesis imperfecta type I is commonly due to a COL1A1 null allele of type I collagen

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methodological considerations in the assessment of health-related quality of life in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclic administration of pamidronate in children with severe osteogenesis imperfecta

1 reference

https://pubmed.ncbi.nlm.nih.gov/17308899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00431-006-0399-2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17308899

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17308899

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48413117&oldid=2209442560"